PharmAust Limited (PAA) is a clinical-stage company developing targeted cancer therapeutics for both humans and animals. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA’s subsidiary, Epichem. PAA’s lead drug candidate is monepantel (MPL), a novel, potent and safe inhibitor of the mTOR pathway – a key driver of cancer.
PharmAust Limited operators in Health Care sector and under industry of Pharmaceuticals. The company website is: http://www.pharmaust.com.
You can also check out dividend history for similar stocks in the same sector as follows:
PAA Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found